Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06824961

Does Increasing the Compression Pause From 3 to 5 Seconds in Mechanical Compression Devices Increase Ventilation Success Rate and Return of Spontaneous Circulation?

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
692 (estimated)
Sponsor
Amsterdam UMC, location VUmc · Academic / Other
Sex
All
Age
16 Years
Healthy volunteers
Not accepted

Summary

To give chest compressions during cardiopulmonary resuscitation (CPR), mechanical chest compression devices can be used. During synchronous 30:2 CPR, the standard setting on these devices leave an automated 3-second chest compression pause after 30 compressions to facilitate caregivers in providing two ventilations. With this standard setting, research has shown that in less than half of ventilation pauses during CPR, those two ventilations are given. Increasing the ventilation pause duration to 5 seconds instead of 3 seconds is also an option following current guideline recommendations, and aligns with measured ventilation pause duration in manual CPR. Increasing pause duration to 5 seconds could result in an increased ventilation success rate. This multicenter randomized controlled trial will randomize LUCAS® mechanical compression devices to a standard setting of 3- or 5-second compression pauses. The main outcome will be the percentage of ventilation pauses in which two ventilations are successfully given. Secondary outcomes include the restoration of spontaneous circulation (ROSC), and the difference in (neurologically intact) survival. No study has been performed to evaluate this effect yet.

Conditions

Interventions

TypeNameDescription
OTHER5-second ventilation pause duration during mechanical CPRThe intervention is a 5-second lasting ventilation pause during mechanical CPR
OTHER3-second ventilation pause duration during mechanical CPRThe intervention is a 3-second lasting ventilation pause during mechanical CPR

Timeline

Start date
2025-03-01
Primary completion
2026-09-01
Completion
2027-04-01
First posted
2025-02-13
Last updated
2025-02-13

Locations

2 sites across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT06824961. Inclusion in this directory is not an endorsement.